SpyGlass Pharma, Inc.
SGP
$24.48
$0.341.41%
NASDAQ
| 12/31/2025 | |||||
|---|---|---|---|---|---|
| Net Income | -49.48% | ||||
| Total Depreciation and Amortization | 101.58% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -68.09% | ||||
| Change in Net Operating Assets | 292.35% | ||||
| Cash from Operations | -49.35% | ||||
| Capital Expenditure | 4.24% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -77.79% | ||||
| Cash from Investing | -85.78% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -86.12% | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -723.84% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -367.36% | ||||